Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Focal adhesion | R-HSA-354113 | map04510 | indapamide | 3702 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | indapamide | 3702 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | indapamide | 3702 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | indapamide | 3702 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | indapamide | 3702 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | indapamide | 3702 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | indapamide | 3702 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | camptothecin | 52925778 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | camptothecin | 52925778 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | camptothecin | 52925778 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | camptothecin | 52925778 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | camptothecin | 52925778 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | camptothecin | 52925778 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | camptothecin | 52925778 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | camptothecin | 52925778 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | camptothecin | 52925778 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | camptothecin | 52925778 | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | camptothecin | 52925778 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | camptothecin | 52925778 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | camptothecin | 52925778 | drug-path |